204 related articles for article (PubMed ID: 29957565)
1. Going knock-Recurrent comatose GHB intoxication in the Netherlands & Flanders (Belgium).
Grund JP; de Bruin D; van Gaalen S
Int J Drug Policy; 2018 Aug; 58():137-148. PubMed ID: 29957565
[TBL] [Abstract][Full Text] [Related]
2. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
Liakoni E; Walther F; Nickel CH; Liechti ME
Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users.
Degenhardt L; Darke S; Dillon P
Addiction; 2003 Feb; 98(2):199-204. PubMed ID: 12534425
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of γ-hydroxybutyrate overdosing.
Korf DJ; Nabben T; Benschop A; Ribbink K; van Amsterdam JG
Eur Addict Res; 2014; 20(2):66-74. PubMed ID: 24080792
[TBL] [Abstract][Full Text] [Related]
5. Understandings, attitudes, practices and responses to GHB overdose among GHB consumers.
Freestone J; Ezard N; Bourne A; Brett J; Roberts DM; Hammoud M; Nedanoski A; Prestage G; Siefried KJ
Harm Reduct J; 2023 Sep; 20(1):121. PubMed ID: 37660058
[TBL] [Abstract][Full Text] [Related]
6. Symptoms and signs in interpreting gamma-hydroxybutyrate (GHB) intoxication - an explorative study.
Stomberg MW; Knudsen K; Stomberg H; Skärsäter I
Scand J Trauma Resusc Emerg Med; 2014 Apr; 22():27. PubMed ID: 24758357
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and dose-effect relationship of clinical gamma-hydroxybutyrate intoxication: A case series.
Abid M; Kietzerow J; Iwersen-Bergmann S; Schnitgerhans T; Andresen-Streichert H
J Forensic Sci; 2022 Jan; 67(1):416-427. PubMed ID: 34523720
[TBL] [Abstract][Full Text] [Related]
8. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.
Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM
Toxicol Lett; 2017 Aug; 277():84-91. PubMed ID: 28579487
[TBL] [Abstract][Full Text] [Related]
9. Demographic and Clinical Characteristics of Regular GHB-Users with and without GHB-Induced Comas.
Raposo Pereira F; McMaster MTB; de Vries YAT; van den Brink W; van Wingen GA
Subst Use Misuse; 2020; 55(13):2148-2155. PubMed ID: 32772606
[TBL] [Abstract][Full Text] [Related]
10. Temporal differences in γ-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: a retrospective study.
Boyd JJ; Kuisma MJ; Randell TT
Scand J Trauma Resusc Emerg Med; 2012 Feb; 20():7. PubMed ID: 22296777
[TBL] [Abstract][Full Text] [Related]
11. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.
Brennan R; Van Hout MC
J Psychoactive Drugs; 2014; 46(3):243-51. PubMed ID: 25052883
[TBL] [Abstract][Full Text] [Related]
12. A multicentre case series of analytically confirmed gamma-hydroxybutyrate intoxications in Western Australian emergency departments: Pre-hospital circumstances, co-detections and clinical outcomes.
Smith JL; Greene S; McCutcheon D; Weber C; Kotkis E; Soderstrom J; Douglas B; Lenton S; Grigg J; Dessauer P; Ezard N; Fatovich DM;
Drug Alcohol Rev; 2024 May; 43(4):984-996. PubMed ID: 38426636
[TBL] [Abstract][Full Text] [Related]
13. Trends in gamma-hydroxybutyrate-related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia.
Arunogiri S; Moayeri F; Crossin R; Killian JJ; Smith K; Scott D; Lubman DI
Addiction; 2020 Mar; 115(3):473-479. PubMed ID: 31618793
[TBL] [Abstract][Full Text] [Related]
14. Trends in illicit drug emergencies: the emerging role of gamma-hydroxybutyrate.
Miró O; Nogué S; Espinosa G; To-Figueras J; Sánchez M
J Toxicol Clin Toxicol; 2002; 40(2):129-35. PubMed ID: 12126184
[TBL] [Abstract][Full Text] [Related]
15. Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL): analysis of overdose cases reported to the Swiss Toxicological Information Centre.
Liechti ME; Kupferschmidt H
Swiss Med Wkly; 2004 Sep; 134(35-36):534-7. PubMed ID: 15517507
[TBL] [Abstract][Full Text] [Related]
16. Effect of intubation for gamma-hydroxybutyric acid overdose on emergency department length of stay and hospital admission.
Dietze P; Horyniak D; Agius P; Munir V; Smit de V; Johnston J; Fry CL; Degenhardt L
Acad Emerg Med; 2014 Nov; 21(11):1226-31. PubMed ID: 25377399
[TBL] [Abstract][Full Text] [Related]
17. Unity in diversity: A systematic review on the GHB using population.
Dijkstra BAG; Beurmanjer H; Goudriaan AE; Schellekens AFA; Joosten EAG
Int J Drug Policy; 2021 Aug; 94():103230. PubMed ID: 33892279
[TBL] [Abstract][Full Text] [Related]
18. [Sudden coma in a 20-year-old man].
Herbrand R; Greminger P; Schurter G; Pletscher W; Kupferschmidt H
Praxis (Bern 1994); 2000 Aug; 89(34):1326-30. PubMed ID: 11021186
[TBL] [Abstract][Full Text] [Related]
19. Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose.
van Amsterdam JG; Brunt TM; McMaster MT; Niesink RJ
Neurosci Biobehav Rev; 2012 Apr; 36(4):1217-27. PubMed ID: 22342779
[TBL] [Abstract][Full Text] [Related]
20. Gamma-hydroxybutyric acid (GHB) measurement by GC-MS in blood, urine and gastric contents, following an acute intoxication in Belgium.
Bodson Q; Denooz R; Serpe P; Charlier C
Acta Clin Belg; 2008; 63(3):200-8. PubMed ID: 18714853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
